Chest nerve block may slash opioid use after heart surgery
NCT ID NCT06546722
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This trial tests whether a targeted nerve block called the Transversus Thoracic Plane Block (TTPB) can reduce pain after cardiac surgery more effectively than standard painkillers. It involves 150 adults scheduled for heart surgery through a chest incision. Researchers also compare giving the block before surgery versus at the end, to see which timing works best.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a nerve block injection of local anesthetic between chest muscles
- What this could lead to
- If effective, TTPB could become a standard way to manage pain after heart surgery, reducing opioid use and speeding recovery.
- What could go wrong
- This is a single-center study with 150 participants, so results may not apply broadly. The block carries rare risks like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
150 people
The number who actually took part.
- Started
-
Sep 2024
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- All patients scheduled for cardiac surgery via sternotomy under cardiopulmonary bypass Exclusion Criteria: * Previous cardiac surgery * Urgent surgery * Pregnant women * Allergy to local anesthetics * Opioid dependence * Low ejection fraction \< 30% * Presence or onset of cognitive or neurological disorders preventing pain assessment * Infection at injection sites * Coagulopathy * Patients on dual antiplatelet therapy * Renal insufficiency with Glomerular filtration rate (GFR) \< 30 mL/min * History of thoracic radiotherapy * History of mastectomy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiac surgery are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hotel Dieu de France
Beirut, 166830, Lebanon
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Post-Operative physical activity monitoring: algorithm performance and clinical outcomes
- Analgesic requirement for Post-Operative pain control in elective 1-3 level transforaminal lumbar interbody fusion: comparison of thoracolumbar interfascial plane block with exparel to bupivacaine HCl
- Could a simple mineral calm the Body's Post-Surgery fire?
- Nanoparticle cleaning may calm pain after failed root canals in diabetic patients
- One pill before surgery may cut opioid use and improve sleep
- Minute-by-Minute urine tracking may sharpen fluid care after heart surgery